Enhancing Effectiveness of drugs Against Prostate Cancer by Angela Mohan on April 21, 2021 at 5:04 PM
Advanced Functional Materials.
Researchers also investigated whether this system helps more drugs across the vessel wall and deeply into the tumor tissue.
Although nucleotide drugs offer advantages in treating tumors and other diseases, they often suffer from a poor efficiency of crossing the blood vessels and entering the tumor tissue, where their targets reside. This problem greatly limits their clinical applicability and efficacy. Our system demonstrates a good ability to deliver more ASOs into both primary tumor tissue and bone metastases which is the primary site for prostate cancer metastasis, said Pang, an assistant professor in the College of Pharmacy and a member of the Masonic Cancer Center.
Prostate Cancer Drug Can Treat Uterine Fibroids medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
ADT May Cause Side Effects in Prostate Cancer Patients by Angela Mohan on January 6, 2021 at 12:16 PM
ADT reduces the level of testosterone and other androgens in the body causing fatigue, depression and cognitive impairment among prostate cancer patients.
Moffitt Cancer Center researchers are investigating whether inflammation in the body, a side effect of ADT, contributes to these symptoms in prostate cancer patients.
In a new study published in the journal
Cancer, they pinpoint a specific inflammation marker that is associated with increased fatigue in this group of patients. This is the first study that we know of that examines the association between inflammation and symptoms of fatigue, depression or cognitive impairment in prostate cancer patients receiving ADT, said Heather Jim, Ph.D., corresponding author and co-leader of the Health Outcomes & Behavior Program at Moffitt.